Intra-Cellular Therapies stock jumps 34%: Can it ride the wave?
Intra-Cellular Therapies Inc. shares soared 34.07% today, closing at $127.19 after gaining $32.32, driven by the announcement of its acquisition by Johnson & Johnson for $14.6 billion. The deal offers...